癌症研究中的药物再利用:一个文献计量分析
Uche Samuel Ndidi1, Israel Ogwuche Ogra2,3, Emohchonne Utos Jonathan4
1Department of Biochemistry, Ahmadu Bello University, Zaria, Kaduna State, Nigeria. usndidi@abu.edu.ng.
Discover oncology
|October 1, 2025
概括
用于癌症研究的药物重新定位正在迅速扩大,美国和中国是主要贡献者. 关键领域包括抗瘤活性,潘托普拉和跨井检测显示出新兴趋势.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 图书统计学 图书统计学
背景情况:
- 癌症是一个重大的全球健康挑战.
- 药物再利用提供了一种有效的策略,通过利用现有药物来识别新的癌症候选药物.
- 图书统计分析提供了关于这一领域的研究趋势和发展的全面概述.
研究的目的:
- 评估癌症研究中药物再利用的现状,焦点和趋势.
- 提供研究发展的详细概述,并确定未来的研究方向.
- 分析2008-2024年的出版数据,以了解该领域的发展轨迹.
主要方法:
- 从Scopus数据库 (2008-2024) 中对1166份文档进行了图书统计分析.
- 使用了Bibliometrix R包和VOSviewer进行数据分析.
- 确定了主要的国家,期刊,作者和研究主题.
主要成果:
- 该领域表现出强的年增长率37.49%.
- 美国和中国是最大的贡献国.
- "癌症"和"Oncotarget"是领先的期刊",Pantziarka P"和"Bouche G"是著名的作者.
- 抗瘤活性是一个关键的研究领域,潘托普拉和transwell测试作为趋势主题.
结论:
- 癌症研究中的药物再利用是一个充满活力和不断增长的领域.
- 未来的研究应该探索抗瘤剂,跨井测定和候选药物,如潘托普拉.
- 这项研究为癌症药物重用研究人员提供了宝贵的指导.
更多相关视频
07:50Global and Current Research Trends of Single-Cell Sequencing in Cancer: A Bibliometric and Visualization Study
Published on: April 18, 2025
815
03:08Using Human Differentially Expressed Gene Lists to Perform Downstream Pathway Enrichment Analysis and Target Prioritization
Published on: October 3, 2025
861
相关概念视频
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Mouse Models of Cancer Study
6.3K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.3K
Cancer Survival Analysis
624
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
624
